tiprankstipranks
Filana Therapeutics, Inc. (FLNA)
NASDAQ:FLNA
US Market
FLNA
Filana Therapeutics
RESEARCH TOOLSreports
Want to see FLNA full AI Analyst Report?

Filana Therapeutics (FLNA) Income Statement

3,921 Followers

Filana Therapeutics Income Statement

Last quarter (Q4 2025), Filana Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Filana Therapeutics's net income was $-12.54M. See Filana Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -936.00K$ 0.00$ -89.42M$ -68.03M$ 0.00
Operating Expenses
$ 94.45M$ 141.45M$ 16.53M$ 11.99M$ 32.87M
Depreciation and Amortization
$ 936.00K$ 1.13M$ 1.53M$ 1.30M$ 534.00K
EBITDA
$ -94.45M$ -141.15M$ -104.43M$ -78.72M$ -32.33M
Operating Income
$ -95.39M$ -141.45M$ -105.96M$ -80.02M$ -32.87M
Other Income/Expenses
$ 4.42M$ 117.10M$ 8.74M$ 3.77M$ 483.00K
Pretax Income
$ -90.97M$ -24.34M$ -97.22M$ -76.25M$ -32.38M
Net Income
$ -90.97M$ -24.34M$ -97.22M$ -76.25M$ -32.38M
Per Share Metrics
Basic EPS
$ -1.88$ -0.53$ -2.32$ -1.80$ -0.81
Diluted EPS
$ -1.88$ -0.52$ -2.32$ -1.80$ -0.81
Weighted Average Shares Outstanding
 48.30M 46.33M 41.93M 40.20M 39.41M
Weighted Average Shares Outstanding (Diluted)
 48.30M 46.60M 41.93M 40.20M 39.41M
Currency in USD

Filana Therapeutics Earnings and Revenue History